FI772802A - NYA HYPOTENSIVE MEDEL - Google Patents

NYA HYPOTENSIVE MEDEL

Info

Publication number
FI772802A
FI772802A FI772802A FI772802A FI772802A FI 772802 A FI772802 A FI 772802A FI 772802 A FI772802 A FI 772802A FI 772802 A FI772802 A FI 772802A FI 772802 A FI772802 A FI 772802A
Authority
FI
Finland
Prior art keywords
medel
nya
hypotensive
nya hypotensive
hypotensive medel
Prior art date
Application number
FI772802A
Other languages
Finnish (fi)
Inventor
Jr George Rodger Allen
Jr John William Hanifin
Daniel Bryan Moran
Jay Donald Albright
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/725,597 external-priority patent/US4230705A/en
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of FI772802A publication Critical patent/FI772802A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/145Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C51/00Preparation of carboxylic acids or their salts, halides or anhydrides
    • C07C51/08Preparation of carboxylic acids or their salts, halides or anhydrides from nitriles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/08Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/12Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/14Oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI772802A 1976-09-22 1977-09-22 NYA HYPOTENSIVE MEDEL FI772802A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US05/725,597 US4230705A (en) 1976-09-22 1976-09-22 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazines and their uses in treating anxiety
US73039576A 1976-10-07 1976-10-07
US73547576A 1976-10-26 1976-10-26

Publications (1)

Publication Number Publication Date
FI772802A true FI772802A (en) 1978-03-23

Family

ID=27419081

Family Applications (1)

Application Number Title Priority Date Filing Date
FI772802A FI772802A (en) 1976-09-22 1977-09-22 NYA HYPOTENSIVE MEDEL

Country Status (19)

Country Link
JP (1) JPS5340798A (en)
AR (2) AR218036A1 (en)
AT (1) AT360034B (en)
AU (1) AU513760B2 (en)
BG (1) BG29287A3 (en)
CA (1) CA1080712A (en)
DD (1) DD132586A5 (en)
DE (1) DE2741763A1 (en)
DK (1) DK417377A (en)
ES (3) ES462543A1 (en)
FI (1) FI772802A (en)
FR (1) FR2442848A1 (en)
GB (1) GB1589237A (en)
GR (1) GR71699B (en)
LU (1) LU78150A1 (en)
NL (1) NL7710389A (en)
NO (1) NO773245L (en)
PT (1) PT67067B (en)
RO (1) RO72226A (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR70309B (en) * 1979-10-29 1982-09-08 Dow Chemical Co
FR2473522A1 (en) * 1980-01-16 1981-07-17 Synthelabo NOVEL DIHYDRO-2,3 IMIDAZO (1,2-B) PYRIDAZINE SUBSTITUTED DERIVATIVES AND MEDICAMENTS, PARTICULARLY USEFUL AS ANTIDEPRESSANTS, CONTAINING THEM
EP0036711B1 (en) * 1980-03-22 1985-12-04 Fbc Limited Pesticidal heterocyclic compounds, processes for preparing them, compositions containing them, and their use
DE3217325A1 (en) * 1982-05-08 1983-11-10 Hoechst Ag, 6230 Frankfurt 3-AMINO-6-ARYL-1,2,4-TRIAZOLO (4,3-B) -PYRIDAZINE, THEIR PRODUCTION AND USE
US4487930A (en) * 1982-09-07 1984-12-11 The Dow Chemical Company 6-[(Cyclic amino)alkylamino]-tetrahydrotriazolo[3,4-a]phthalazines
FR2562071B1 (en) * 1984-03-30 1986-12-19 Sanofi Sa TRIAZOLO (4,3-B) PYRIDAZINES, PROCESS FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
US4767765A (en) * 1985-10-31 1988-08-30 American Cyanamid Company N-substituted-N-[3-(1,2,4-triazolo-[4,3-b]pyridazin-6-yl)phenyl]alkanamides, carbamates and ureas
US4654343A (en) * 1985-10-31 1987-03-31 American Cyanamid Company N-substituted-N[3-(1,2,4-triazolo[4,3-b]pyridazin-6-yl)phenyl]alkanamides, carbamates and ureas
PL331072A1 (en) 1996-07-25 1999-06-21 Merck Sharp & Dohme Substututed derivatives of triazolo-pyrydazine as ligands for gaba receptors
AU746866B2 (en) * 1998-01-14 2002-05-02 Merck Sharp & Dohme Limited Triazolo-pyridazine derivatives as ligands for GABA receptors
GB9801202D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801234D0 (en) * 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801210D0 (en) * 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
CN1110498C (en) 1998-01-21 2003-06-04 默克·夏普-道姆公司 Triazolo-pyridzine derivatives as ligands for GABA receptors
GB9801208D0 (en) 1998-01-21 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801397D0 (en) * 1998-01-22 1998-03-18 Merck Sharp & Dohme Therapeutic agents
GB9801538D0 (en) 1998-01-23 1998-03-25 Merck Sharp & Dohme Pharmaceutical product
EP1719756A4 (en) * 2004-02-18 2007-09-26 Banyu Pharma Co Ltd Nitrogenous fused heteroaromatic ring derivative
CA3045121A1 (en) * 2016-11-28 2018-05-31 Praxis Precision Medicines, Inc. Compounds and their methods of use
US11866439B2 (en) 2018-05-30 2024-01-09 Praxis Precision Medicines, Inc. Ion channel modulators
US11773099B2 (en) 2019-05-28 2023-10-03 Praxis Precision Medicines, Inc. Compounds and their methods of use
US11505554B2 (en) 2019-05-31 2022-11-22 Praxis Precision Medicines, Inc. Substituted pyridines as ion channel modulators

Also Published As

Publication number Publication date
FR2442848A1 (en) 1980-06-27
CA1080712A (en) 1980-07-01
ES462543A1 (en) 1979-06-16
PT67067B (en) 1979-02-19
DE2741763A1 (en) 1978-03-23
PT67067A (en) 1977-10-01
AU2899577A (en) 1979-03-29
JPS5340798A (en) 1978-04-13
AU513760B2 (en) 1980-12-18
AR218036A1 (en) 1980-05-15
GB1589237A (en) 1981-05-07
GR71699B (en) 1983-06-21
AR217886A1 (en) 1980-04-30
ES477800A1 (en) 1979-10-16
DK417377A (en) 1978-03-23
LU78150A1 (en) 1978-01-23
NO773245L (en) 1978-03-28
RO72226A (en) 1982-09-09
AT360034B (en) 1980-12-10
ATA677577A (en) 1980-05-15
NL7710389A (en) 1978-03-28
ES477799A1 (en) 1980-04-01
DD132586A5 (en) 1978-10-11
BG29287A3 (en) 1980-10-15

Similar Documents

Publication Publication Date Title
FI771951A (en) NYA HALOSPORINDERIVAT
SE7707734L (en) NEW HYDROXI-SUCCINIMIDO-ESTRAR
FI772802A (en) NYA HYPOTENSIVE MEDEL
SE7604761L (en) NEW POLYPEPTIDER
SE7802867L (en) NEW 4-ACYLAMINO-PHENYL-ETHANOLAMINES
SE7807642L (en) NEW 1-ACYL-2-CYANAZIRIDINES
FI772915A (en) FOERFARANDE FOR FRAMSTAELLNING AV NYA ANTHRACYCLINANTIBIOTICS
FI772832A (en) TILLVAEXTREGLERANDE MEDEL FOER VAEXTER
FI55353C (en) FOERFARANDE FOER FRAMSTAELLNING AV NYA ANTHRACYCLINANTIBIOTICS
SE7514776L (en) NEW SUBSTITUTED PERHALOGENALKYLAMIDINES
FI781461A (en) FOERFARANDE FOER FRAMSTAELLNING AV NYA ALKYLENDIAMINDERIVAT
FI773717A (en) NYA AMINOALKOXIFENYLDERIVATER
FI56525B (en) NYA KROMOGENA TROMBINSUBSTRAT
SE7810050L (en) NEW 7-AZABENSIMIDAZOLES
FI781674A (en) NYA FLUORIDERADE AMINOSYROR
SE7712387L (en) NEW MORPHANITRIDINES
FI772565A (en) FOERFARANDE FOER FRAMSTAELLNING AV NYA BENSOPYRANDERIVAT
FI772394A (en) NYA BEHENSYRAESTRAR
FI772921A (en) NYA CORTECOIDER
SE7808018L (en) NEW IMIDAZO-ISOKINOLIN DIONER
SE7703948L (en) NEW ANIBACTERIAL ASSOCIATIONS
FI782228A (en) FOERFARANDE FOER FRAMSTAELLNING AV NYA BENSOPYRANDERIVAT
FI780444A (en) FOERFARANDE FOER FRAMSTAELLNING AV NYA OXIMDERIVAT AV 3-THIADIAZOLYLTHOMETHYL-7-AMINOTIAZOLACETAMIDO-CEPHALOSPORANSYRA
FI773743A (en) FOERFARANDE FOER FRAMSTAELLNING AV NYA PIPERAZINDERIVAT
SE7804318L (en) NEW NAFTYRIDINES

Legal Events

Date Code Title Description
FD Application lapsed

Owner name: AMERICAN CYANAMID COMPANY